Aveo Pharmaceuticals Inc. buy melinda
Start price
31.07.18
/
50%
€19.21
Target price
29.08.18
€26.16
Performance (%)
29.58%
End price
29.08.18
€24.90
Summary
This prediction ended on 29.08.18 with a price of €24.90. The prediction had a final performance of 29.58%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aveo Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by melinda for this prediction
In the thread Aveo Pharmaceuticals diskutieren
SecteurRecherche biotechnologique et médicale Agenda 07/11 Publication de résultats
Researchs and develops cancer therapeutics
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need.
Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380, and AV-353.
The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need.
Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380, and AV-353.
The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.
Nombre d'employés : 19 personnes.
Stopped prediction by melinda for Aveo Pharmaceuticals Inc.
Aveo Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€3.96
31.08.20
31.08.20
€6.00
04.11.21
04.11.21
59.22%
05.11.21
05.11.21
Aveo Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.50
04.05.20
04.05.20
-
31.08.20
31.08.20
-39.08%
31.08.20
31.08.20
Aveo Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.88
29.03.19
29.03.19
€18.04
03.04.19
03.04.19
67.71%
03.04.19
03.04.19
Aveo Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.53
19.01.18
19.01.18
€27.96
31.01.18
31.01.18
9.54%
31.01.18
31.01.18
Aveo Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€37.25
06.10.17
06.10.17
€45.10
26.12.17
26.12.17
-27.36%
26.12.17
26.12.17
Aveo Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€30.85
31.08.17
31.08.17
€36.08
07.09.17
07.09.17
17.54%
07.09.17
07.09.17
Aveo Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.90
30.06.17
30.06.17
€23.50
30.06.17
30.06.17
-3.20%
30.06.17
30.06.17
Aveo Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€19.75
30.06.17
30.06.17
€21.20
30.06.17
30.06.17
-3.20%
30.06.17
30.06.17
Aveo Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€15.83
26.06.17
26.06.17
€18.04
27.06.17
27.06.17
13.39%
27.06.17
27.06.17
Aveo Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.28
11.03.17
11.03.17
€15.33
26.06.17
26.06.17
90.67%
26.06.17
26.06.17
Aveo Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€20.94
03.05.13
03.05.13
€50.00
04.11.13
04.11.13
-26.89%
04.11.13
04.11.13